A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma

Oncogene, Published online: 07 October 2019; doi:10.1038/s41388-019-1044-7A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma

Source: Oncogene - October 6, 2019 Category: Cancer & Oncology Authors: Stefan Salcher Gilles Spoden Judith Hagenbuchner Sebastian F ührer Teresa Kaserer Martin Tollinger Petra Huber-Cantonati Thomas Gruber Daniela Schuster Ronald Gust Heinz Zwierzina Thomas M üller Ursula Kiechl-Kohlendorfer Michael J. Ausserlechner Petra Source Type: research